Information:
Error:
ID
35055
Description
Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02483767
Link
https://clinicaltrials.gov/show/NCT02483767
Keywords
Versions (1)
- 2/12/19 2/12/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
February 12, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT02483767
Eligibility Breast Cancer NCT02483767
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT02483767
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Informed Consent
Item
the patients signed the written informed consent.
boolean
C0021430 (UMLS CUI [1])
Breast Carcinoma TNM Breast tumor staging
Item
histologically proven stage i, ii, or iii breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,2])
Patients Appropriate Adjuvant Chemotherapy | Patients Appropriate Chemotherapy Neoadjuvant
Item
must be candidates for adjuvant or neoadjuvant chemotherapy,
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0085533 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C1548787 (UMLS CUI [2,2])
C0392920 (UMLS CUI [2,3])
C1298676 (UMLS CUI [2,4])
C1548787 (UMLS CUI [1,2])
C0085533 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C1548787 (UMLS CUI [2,2])
C0392920 (UMLS CUI [2,3])
C1298676 (UMLS CUI [2,4])
Premenopausal state
Item
must be premenopausal.
boolean
C0232969 (UMLS CUI [1])
trastuzumab | Tumor HER2 Overexpression
Item
trastuzumab is permitted in patients with human epidermal growth factor receptor 2 (her2) overexpressing tumors.
boolean
C0728747 (UMLS CUI [1])
C0027651 (UMLS CUI [2,1])
C0069515 (UMLS CUI [2,2])
C1514559 (UMLS CUI [2,3])
C0027651 (UMLS CUI [2,1])
C0069515 (UMLS CUI [2,2])
C1514559 (UMLS CUI [2,3])
Prior Chemotherapy
Item
the patients were previous chemotherapy;
boolean
C1514457 (UMLS CUI [1])
Distant metastasis
Item
evidence of distant metastases;
boolean
C1269798 (UMLS CUI [1])
Cancer Other
Item
other malignancies in the previous 5 years.
boolean
C1707251 (UMLS CUI [1])
Gonadotropin releasing hormone agonists (GNRH-A) | Progesterone | Ovulation Stimulation Drugs | Contraceptives, Oral | Aromatase Inhibitors | Intrauterine Devices Hormonal | Subcutaneous contraceptive | Hormone Therapy Drugs
Item
the patients were using gnrha, progesterone, stimulate ovulation drugs, oral contraceptives, aromatase inhibitors, intrauterine device with hormone, subcutaneous preparations contraceptive drugs such as hormone drugs and instruments during 3 month preceding the start of chemotherapy.
boolean
C2012324 (UMLS CUI [1])
C0033308 (UMLS CUI [2])
C0029965 (UMLS CUI [3,1])
C1292856 (UMLS CUI [3,2])
C0013227 (UMLS CUI [3,3])
C0009905 (UMLS CUI [4])
C0593802 (UMLS CUI [5])
C0021900 (UMLS CUI [6,1])
C0458083 (UMLS CUI [6,2])
C0459222 (UMLS CUI [7])
C0279025 (UMLS CUI [8,1])
C0013227 (UMLS CUI [8,2])
C0033308 (UMLS CUI [2])
C0029965 (UMLS CUI [3,1])
C1292856 (UMLS CUI [3,2])
C0013227 (UMLS CUI [3,3])
C0009905 (UMLS CUI [4])
C0593802 (UMLS CUI [5])
C0021900 (UMLS CUI [6,1])
C0458083 (UMLS CUI [6,2])
C0459222 (UMLS CUI [7])
C0279025 (UMLS CUI [8,1])
C0013227 (UMLS CUI [8,2])
Pregnancy | Breast Feeding
Item
pregnancy or lactation.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])